March 11 (Reuters) - Coeptis Therapeutics Holdings Inc COEP.O:
COEPTIS THERAPEUTICS: SECURES WORLDWIDE DEVELOPMENT & COMMERCIALIZATION RIGHTS TO NEXT-GENERATION GEAR CELL THERAPY PLATFORM
COEPTIS THERAPEUTICS: FORMED NEW MAJORITY-OWNED SUBSIDIARY, GEAR THERAPEUTICS, INC.
COEPTIS THERAPEUTICS: GEAR LICENSE AGREEMENT WITH VYGEN-BIO
Source text: ID:nGNX6BgshH
Further company coverage: COEP.O
((Reuters.Briefs@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。